Medical Clinic for Nephrology and Internal Intensive Care, Campus Virchow Klinikum, Experimental and Clinical Research Center and Max-Delbrück Center of Molecular Medicine, Berlin, Germany.
J Hypertens. 2010 Sep;28(9):1875-82. doi: 10.1097/HJH.0b013e32833c20d5.
Perivascular adipose tissue secretes an adipocyte-derived relaxing factor (ADRF) that opens voltage-dependent K (Kv) channels in peripheral arteries. We studied the role of KCNQ-type Kv channels and tested the hypothesis that hydrogen sulfide (H2S) could be an ADRF.
We performed isometric contraction studies on systemic arteries of rats and mice.
In mesenteric arteries and aortas without perivascular adipose tissue, the KCNQ channel openers retigabine, VRX0530727, VRX0621238, and VRX0621688 produced concentration-dependent vasorelaxation; VRX0621688 was the most potent vasodilator. The KCNQ inhibitor XE991 (30 micromol/l) blocked the effects of both the drugs and ADRF. Inhibitors of cystathionine gamma lyase (CSE) beta-cyano-L-alanine (BCA, 5 mmol/l) and 4-propargyl glycine (PPG, 10 mmol/l) also blocked the relaxations. CSE is expressed in perivascular adipose tissue and endogenously generates H2S. The H2S donor NaHS produced concentration-dependent vasorelaxation, which was also blocked by XE991. The vasodilatory capacities of retigabine, VRX0530727, VRX0621238, and VRX0621688 were preserved following inhibition of H2S generation in perivascular fat.
We suggest that KCNQ channel opening is a powerful mechanism to produce vasorelaxation of systemic arteries in rats and mice. Furthermore, KCNQ channels play a major role in the paracrine control of vascular tone by perivascular adipose tissue, which is at least in part mediated or modulated by H2S. In conditions of reduced H2S release from perivascular adipose tissue, these paracrine effects can be mimicked by synthetic KCNQ channel openers.
血管周脂肪组织分泌一种脂肪细胞衍生的舒张因子(ADRF),可打开外周动脉中的电压依赖性 K(Kv)通道。我们研究了 KCNQ 型 Kv 通道的作用,并验证了假说,即硫化氢(H2S)可能是 ADRF。
我们对大鼠和小鼠的系统性动脉进行等长收缩研究。
在没有血管周脂肪组织的肠系膜动脉和主动脉中,KCNQ 通道开放剂瑞替加滨、VRX0530727、VRX0621238 和 VRX0621688 产生浓度依赖性血管舒张;VRX0621688 是最强的血管舒张剂。KCNQ 抑制剂 XE991(30 μmol/L)阻断了药物和 ADRF 的作用。半胱氨酸γ裂解酶(CSE)抑制剂β-氰基-L-丙氨酸(BCA,5 mmol/L)和 4-炔丙基甘氨酸(PPG,10 mmol/L)也阻断了松弛作用。CSE 在血管周脂肪组织中表达,并内源性产生 H2S。H2S 供体 NaHS 产生浓度依赖性血管舒张,该舒张作用也被 XE991 阻断。在抑制血管周脂肪中 H2S 生成后,瑞替加滨、VRX0530727、VRX0621238 和 VRX0621688 的血管舒张能力得以保留。
我们认为 KCNQ 通道开放是大鼠和小鼠系统性动脉产生血管舒张的一种强大机制。此外,KCNQ 通道在血管周脂肪组织对血管张力的旁分泌控制中起主要作用,至少部分是由 H2S 介导或调节的。在血管周脂肪组织释放 H2S 减少的情况下,这些旁分泌作用可以被合成的 KCNQ 通道开放剂模拟。